| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Letters to the Editor |
British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
VU University Medical Center, Amsterdam, the Netherlands
To the Editor:
We read with interest the publication by Greshock and colleagues (1). Side by side comparison of array comparative genomic hybridization platforms has become a hot topic and several reports have aimed to evaluate various arrays to facilitate the user's selection of the appropriate platform (2–5). Greshock and colleagues used an interesting and meaningful approach to compare the sensitivity and specificity of three popular oligonucleotide comparative genomic hybridization platforms by receiver operating characteristic curve analysis of actual experimental results. The finding that the averaging of multiple array elements is platform-dependent and is required to reduce noise on some platforms matches well with previous reports (2, 3).
Previous reports disagree with respect to two pivotal issues, resolution and coverage. The usage and definition of the term "resolution" in the manuscript is debatable. Greshock and colleagues define resolution in terms of mean probe spacing, which distorts the estimate of true performance when array elements are unevenly distributed. Thus, the genomic distribution of array elements has to be considered in determining resolution. For example, the Affymetrix 500K (AF500K) array is defined in the manuscript as having a resolution of 17.7 Kbp (1), whereas distribution-dependent metrics have defined the array's performance at this level as allowing detection of 58% (2) of 1.5-fold alterations this size. In fact, our study suggests that AF500K is only likely to reliably (95%) detect alterations of
75 Kbp (2).
Additionally, the authors state that the Affymetrix AF500K array, offers "broader and more even coverage across the genome" than the Agilent AG244K array (1). However, we found similar detection probabilities between these platforms at all alteration sizes (2). Our finding contradicts the authors' statement as 244,000 elements should not detect alterations at the same frequency as 500,000 elements, unless the AF500K platform is less evenly distributed. These conflicting results can perhaps be explained by the comparison of only threshold-segmented regions of high-level alteration. Given the biases induced in probe reduction, including restriction digestion combined with PCR (AF500K) as opposed to Random Prime–based labeling (AG244K) it is likely that specific ratio cutoffs may detect different regions. For this reason, the use of automated segmentation algorithms for the comparison of detected regions as shown by Hehir-Kwa and colleagues (3), Paris and colleagues (4), and Wicker and colleagues (5) is likely a more accurate methodology.
Overall, we appreciate the importance of this study; however, we believe that the discussion of resolution and comparison of alteration detection is inaccurate.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
References
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |